Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Mariana Jinga

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5826-0815; OpenAlex author ID A5068375538. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
29
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 3 papers · 2023: none · 2024: none · 2025: 1 paper · 2026: 3 papers

Papers 8

  1. Distinct Inflammatory and Dissemination Signatures Defined by Macrophage Migration Inhibitory Factor (MIF), Interleukin-8 (IL-8/CXCL8), and Stem Cell Factor (S… Co-author DOI 10.3390/diagnostics16091373↗
  2. Pancreatic Steatosis and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Systematic Review of the Current Evidence. Last author DOI 10.3390/diagnostics16152476↗
  3. Clinical Significance of Cytokeratin 19-Fragments (CYFRA 21-1), Osteopontin (OPN) and Human Epididymis Protein 4 (HE4) in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/ijms27031562↗
  4. Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Adenocarcinoma: A Scoping Review with Meta-Analysis. Co-author DOI 10.3390/diagnostics15040437↗
  5. Transverse colon varices as a diagnostic hint for pancreatic cancer. Co-author DOI 10.15403/jgld-4355↗
  6. Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects. Last author DOI 10.3390/ijms231710132↗
  7. Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer. Last author DOI 10.5306/wjco.v13.i7.630↗
  8. Changes in tumor vascularity depicted by contrast-enhanced EUS as a predictor of prognosis and treatment efficacy in patients with unresectable pancreatic canc… Co-author DOI 10.4103/eus.eus_16_19↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel Vasile Balaban · 5 shared papers, 2022–2026 · strength 1.45
  2. Augustin Cătălin Dima · 2 shared papers, 2026 · strength 0.54
  3. Cătălin Cârstoiu · 2 shared papers, 2026 · strength 0.54
  4. Săndica Bucurica · 2 shared papers, 2022 · strength 0.37
  5. Stephen P. Pereira · 2 shared papers, 2019–2025 · strength 0.34
  6. Adrian Săftoiu · 2 shared papers, 2019–2025 · strength 0.34
  7. Daniela Tabacelia · 1 shared paper, 2025 · strength 0.27
  8. Cristian George Ţieranu · 1 shared paper, 2025 · strength 0.27
  9. Cristian Gheorghe · 1 shared paper, 2025 · strength 0.27
  10. Monica Grigore · 1 shared paper, 2022 · strength 0.22
  11. Silviu Stanciu · 1 shared paper, 2022 · strength 0.16
  12. Cătălina Vlăduţ · 1 shared paper, 2022 · strength 0.14
  13. JulioIglesias Garcia · 1 shared paper, 2019 · strength 0.07
  14. Michael Hocke · 1 shared paper, 2019 · strength 0.07
  15. ChristophF Dietrich · 1 shared paper, 2019 · strength 0.07
  16. Alina Liliana Constantin · 1 shared paper, 2019 · strength 0.07
  17. Irina Mihaela Cazacu · 1 shared paper, 2019 · strength 0.07
  18. Peter Vilmann · 1 shared paper, 2019 · strength 0.07
  19. Emmanuel S. Coronel · 1 shared paper, 2019 · strength 0.07
  20. Maria Chiara Petrone · 1 shared paper, 2019 · strength 0.07
  21. Paul Yeaton · 1 shared paper, 2019 · strength 0.07
  22. Andrada Seicean · 1 shared paper, 2019 · strength 0.07
  23. Kofi W. Oppong · 1 shared paper, 2019 · strength 0.07
  24. Dong Wan Seo · 1 shared paper, 2019 · strength 0.07
  25. Irving Waxman · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.